Pharmaceutical and professional services industries outrank retail and telecom sectors in employee well-being efforts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
UBS Reiterates Buy on Cigna Corp. (CI) Following 3Q
November 9, 2015 10:54 AM ESTUBS reiterated a Buy rating on CIGNA (NYSE: CI), and cut the price target to $172.00 (from $175.00), following the company's 3Q earnings report. For 2016, Cigna expects to maintain its public exchange footprint. Cigna participated in limited markets in eight states for 2015, and the company is... More
Positive Operating Execution and SG&A Improvement Drives EPS Beat For Cigna Corp. (CI); Wedbush Remains Neutral
November 9, 2015 8:01 AM ESTWedbush maintained a Neutral rating on CIGNA (NYSE: CI), and cut the price target to $175.00 (from $186.00), following the company's 3Q15 earnings report. Adjusted EPS of $2.28, vs. consensus of $2.20, was driven by positive operating execution with better than expected SG&A improvement. 2015 EPS guidance was raised to $8.40-8.60 from $8.30-8.60 vs. consensus of $8.62.
Analyst Sarah James commented, "Adjusted EPS of $2.28 vs.... More



